UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials

Annals of oncology, 2017-08, Vol.28 (8), p.1713-1729

2017

Volltextzugriff (PDF)

Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer

Annals of oncology, 2013-01, Vol.24 (1), p.20-30

2013

Volltextzugriff (PDF)

Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis

Annals of oncology, 2016-10, Vol.27 (10), p.1818-1828

2016

Volltextzugriff (PDF)

PD-L1 protein expression assessed by immunohistochemistry is neither prognostic nor predictive of benefit from adjuvant chemotherapy in resected non-small cell lung cancer

Annals of oncology, 2017-04, Vol.28 (4), p.882-889

2017

Volltextzugriff (PDF)

Ventilator-associated pneumonia and bloodstream infections in intensive care unit cancer patients: a retrospective 12-year study on 3388 prospectively monitored patients

Supportive care in cancer, 2020-01, Vol.28 (1), p.193-200

2020

Volltextzugriff (PDF)

Immunogenic death of colon cancer cells treated with oxaliplatin

Oncogene, 2010-01, Vol.29 (4), p.482-491

2010

Volltextzugriff (PDF)

Efficacy and safety of bevacizumab-based combination regimens in patients with previously untreated metastatic colorectal cancer: Final results from a randomised phase ii study of bevacizumab plus 5-fluorouracil, leucovorin plus irinotecan versus bevacizumab plus capecitabine plus irinotecan (FNCLCC ACCORD 13/0503 study)

European journal of cancer (1990), 2013-04, Vol.49 (6), p.1236-1245

2013

Volltextzugriff (PDF)

Unexpected toxicity of cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: results of the UNICANCER ACCORD 16 phase II trial

Annals of oncology, 2013-11, Vol.24 (11), p.2834-2838

2013

Volltextzugriff (PDF)

Adjuvant cisplatin-based chemotherapy in nonsmall-cell lung cancer: new insights into the effect on failure type via a multistate approach

Annals of oncology, 2014-11, Vol.25 (11), p.2162-2166

2014

Volltextzugriff (PDF)

Phase I trial of everolimus in combination with thoracic radiotherapy in non-small-cell lung cancer

Annals of oncology, 2015-06, Vol.26 (6), p.1223-1229

2015

Volltextzugriff (PDF)

Treatment outcome and survival in participants of phase I oncology trials carried out from 2003 to 2006 at Institut Gustave Roussy

Annals of oncology, 2008-04, Vol.19 (4), p.787-792

2008

Volltextzugriff (PDF)

Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: Results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601

European journal of cancer (1990), 2013-01, Vol.49 (1), p.90-97

2013

Volltextzugriff (PDF)

Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases

British journal of surgery, 2003-05, Vol.90 (5), p.567-574

2003

Volltextzugriff (PDF)

Cisplatin benefit is predicted by immunohistochemical analysis of DNA repair proteins in squamous cell carcinoma but not adenocarcinoma: theranostic modeling by NSCLC constituent histological subclasses

Annals of oncology, 2012-09, Vol.23 (9), p.2245-2252

2012

Volltextzugriff (PDF)

Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): A meta-analysis of individual data from 1764 patients

Annals of oncology, 2006-03, Vol.17 (3), p.473-483

2006

Volltextzugriff (PDF)

Nasopharyngeal carcinomas: an update

European Journal of Cancer, 2003-10, Vol.39 (15), p.2121-2135

2003

Volltextzugriff (PDF)

Cross-validation study of class III beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of four randomized trials

Annals of oncology, 2012-01, Vol.23 (1), p.86-93

2012

Volltextzugriff (PDF)

Does KRAS mutational status predict chemoresistance in advanced non-small cell lung cancer (NSCLC)?

Lung cancer (Amsterdam, Netherlands), 2014-03, Vol.83 (3), p.383-388

2014

Volltextzugriff (PDF)

Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution

Annals of oncology, 2002-02, Vol.13 (2), p.267-272

2002

Volltextzugriff (PDF)

Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer

Annals of oncology, 2014-09, Vol.25 (9), p.1865-1866

2014

Volltextzugriff (PDF)

Individual patient data network meta-analysis using either restricted mean survival time difference or hazard ratios: is there a difference? A case study on locoregionally advanced nasopharyngeal carcinomas

Systematic reviews, 2019-04, Vol.8 (1), p.96-96, Article 96

2019

Volltextzugriff (PDF)

Taking into account successive treatment lines in the analysis of a colorectal cancer randomised trial

European journal of cancer (1990), 2013-05, Vol.49 (8), p.1882-1888

2013

Volltextzugriff (PDF)

The effect of the UGT1A128 allele on survival after irinotecan-based chemotherapy: a collaborative meta-analysis

The pharmacogenomics journal, 2014-10, Vol.14 (5), p.424-431

2014

Volltextzugriff (PDF)

Multicentre phase II trial of capecitabine plus oxaliplatin (XELOX) in patients with advanced hepatocellular carcinoma: FFCD 03-03 trial

British journal of cancer, 2007-10, Vol.97 (7), p.862-867

2007

Volltextzugriff (PDF)

PRODIGE 29-UCGI 26(NEOPAN): A randomised trial of chemotherapy with folfirinox or gemcitabine in locally advanced pancreatic carcinoma (PC)

Annals of oncology, 2018-10, Vol.29, p.viii266-viii267

2018

Volltextzugriff (PDF)

1 – 25 von 511

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(439)
Mit Volltextzugriff
(415)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(265)
Science & Technology
(254)
Life Sciences & Biomedicine
(236)
Male
(136)
Female
(131)
Biological And Medical Sciences
(119)
Oncology
(119)
Medical Sciences
(114)
Middle Aged
(114)
Aged
(88)
Adult
(81)
Chemotherapy
(57)
Prognosis
(55)
Randomized Controlled Trials As Topic
(54)
Treatment Outcome
(53)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(51)
Survival Analysis
(50)
Pharmacology. Drug Treatments
(49)
Meta-Analysis As Topic
(42)
Disease-Free Survival
(41)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials

Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer

Impact of thoracic radiotherapy timing in limited-stage small-cell lung cancer: usefulness of the individual patient data meta-analysis

PD-L1 protein expression assessed by immunohistochemistry is neither prognostic nor predictive of benefit from adjuvant chemotherapy in resected non-small cell lung cancer

Ventilator-associated pneumonia and bloodstream infections in intensive care unit cancer patients: a retrospective 12-year study on 3388 prospectively monitored patients

Immunogenic death of colon cancer cells treated with oxaliplatin

Unexpected toxicity of cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: results of the UNICANCER ACCORD 16 phase II trial

Adjuvant cisplatin-based chemotherapy in nonsmall-cell lung cancer: new insights into the effect on failure type via a multistate approach

Phase I trial of everolimus in combination with thoracic radiotherapy in non-small-cell lung cancer

Treatment outcome and survival in participants of phase I oncology trials carried out from 2003 to 2006 at Institut Gustave Roussy

Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: Results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601

Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases

Cisplatin benefit is predicted by immunohistochemical analysis of DNA repair proteins in squamous cell carcinoma but not adenocarcinoma: theranostic modeling by NSCLC constituent histological subclasses

Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): A meta-analysis of individual data from 1764 patients

Nasopharyngeal carcinomas: an update

Cross-validation study of class III beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of four randomized trials

Does KRAS mutational status predict chemoresistance in advanced non-small cell lung cancer (NSCLC)?

Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution

Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer

Individual patient data network meta-analysis using either restricted mean survival time difference or hazard ratios: is there a difference? A case study on locoregionally advanced nasopharyngeal carcinomas

Taking into account successive treatment lines in the analysis of a colorectal cancer randomised trial

The effect of the UGT1A128 allele on survival after irinotecan-based chemotherapy: a collaborative meta-analysis

Multicentre phase II trial of capecitabine plus oxaliplatin (XELOX) in patients with advanced hepatocellular carcinoma: FFCD 03-03 trial

PRODIGE 29-UCGI 26(NEOPAN): A randomised trial of chemotherapy with folfirinox or gemcitabine in locally advanced pancreatic carcinoma (PC)

Suchergebnisse filtern